Discuss This Drug

dalbavancin

CHEBI:CHEBI_82721

Definition

A semisynthetic glycopeptide used for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA.

Chemical Information

Molecular Formula
C88H100Cl2N10O28
Molecular Mass
1816.69200
Charge
0
SMILES
CN[C@@H]1c2ccc(O)c(Oc3cc(O)c(Cl)c(c3)[C@@H]3NC(=O)[C@@H](Cc4ccc(Oc5cc6cc(Oc7ccc(cc7Cl)[C@@H](O)[C@@H]7NC(=O)[C@H](NC(=O)[C@@H]6NC3=O)c3ccc(O)c(c3)-c3c(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)cc(O)cc3[C@H](NC7=O)C(=O)NCCCN(C)C)c5O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)C(O)=O)cc4)NC1=O)c2
InChI
InChI=1S/C88H100Cl2N10O28/c1-38(2)13-10-8-6-7-9-11-14-61(106)94-70-73(109)75(111)78(86(120)121)128-87(70)127-77-58-31-43-32-59(77)124-55-24-19-42(29-50(55)89)71(107)69-85(119)98-67(80(114)92-25-12-26-100(4)5)48-33-44(102)34-57(125-88-76(112)74(110)72(108)60(37-101)126-88)62(48)47-28-40(17-22-52(47)103)65(82(116)99-69)95-83(117)66(43)96-84(118)68-49-35-46(36-54(105)63(49)90)123-56-30-41(18-23-53(56)104)64(91-3)81(115)93-51(79(113)97-68)27-39-15-20-45(122-58)21-16-39/h15-24,28-36,38,51,60,64-76,78,87-88,91,101-105,107-112H,6-14,25-27,37H2,1-5H3,(H,92,114)(H,93,115)(H,94,106)(H,95,117)(H,96,118)(H,97,113)(H,98,119)(H,99,116)(H,120,121)/t51-,60-,64-,65-,66-,67+,68+,69+,70-,71-,72-,73-,74+,75+,76+,78+,87-,88+/m1/s1
InChIKey
KGPGQDLTDHGEGT-SZUNQUCBSA-N

Alternative Names

  • BI 397
  • BI397
  • dalbavancin
  • dalbavancin B0

Treatment Applications

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
1539239
oboInOwl#hasDbXref
Wikipedia:Dalbavancin
core#notation
CHEBI:82721

Additional References

Wikipedia:Dalbavancin

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
1539239
oboInOwl#hasDbXref
Wikipedia:Dalbavancin
oboInOwl#id
CHEBI:82721
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
labeler_name
EUROAPI Italy SRL
listing_expiration_date
20251231
dosage_form
INJECTION, POWDER, FOR SOLUTION
route
INTRAVENOUS
marketing_start_date
20160921
package_marketing_start_date
26-DEC-22
generic_name
Dalbavancin hydrochloride
brand_name
DALVANCE
brand_name_base
DALVANCE
product_ndc
52076-6279
application_number
NDA021883
spl_id
05395884-014b-1c6d-e063-6294a90abfcc
package_ndc
52076-6279-1
package_description
50 kg in 1 DRUM (52076-6279-1)
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_36047
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
core#notation
CHEBI:82721
rxcui
1539248
manufacturer_name
Allergan, Inc.
active_ingredient_strength
500 mg/25mL
pharm_class
Lipoglycopeptides [CS]
active_ingredient_name
DALBAVANCIN B0
unii
33WDQ7T81E
spl_set_id
4b4674d8-4d1e-4728-8465-d42ada33fa5c
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#range
https://w3id.org/def/predibionto#has_drug_113564
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect36361
owl#annotatedSource
t304141
owl#someValuesFrom
t3046432